X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
parkinson's disease (106) 106
humans (92) 92
continuous dopaminergic stimulation (88) 88
parkinson disease - drug therapy (80) 80
index medicus (76) 76
clinical neurology (66) 66
motor fluctuations (54) 54
animals (51) 51
levodopa (46) 46
neurosciences (45) 45
apomorphine (43) 43
antiparkinson agents - administration & dosage (42) 42
male (39) 39
pharmacology & pharmacy (39) 39
antiparkinson agents - therapeutic use (38) 38
double-blind (37) 37
motor complications (37) 37
dyskinesia (35) 35
levodopa - administration & dosage (33) 33
neurology (33) 33
levodopa - therapeutic use (30) 30
dopamine (29) 29
female (27) 27
antiparkinson agents - adverse effects (26) 26
dopa (24) 24
dopamine agonists - administration & dosage (24) 24
duodenal levodopa infusion (24) 24
l-dopa (23) 23
quality-of-life (23) 23
dyskinesias (22) 22
levodopa - adverse effects (22) 22
apomorphine - administration & dosage (21) 21
treatment outcome (21) 21
parkinson disease - physiopathology (19) 19
aged (18) 18
deep brain stimulation (18) 18
middle aged (18) 18
rats (18) 18
advanced parkinsons-disease (17) 17
drug administration schedule (17) 17
subcutaneous apomorphine (17) 17
antiparkinson agents - pharmacokinetics (16) 16
dopamine agonists - therapeutic use (15) 15
psychiatry (15) 15
subthalamic nucleus (15) 15
deep-brain-stimulation (14) 14
dopamine agonists - adverse effects (14) 14
drug therapy (14) 14
parkinson disease - complications (14) 14
analysis (13) 13
duodopa (13) 13
motor activity - drug effects (13) 13
parkinson’s disease (13) 13
rats, sprague-dawley (13) 13
time factors (13) 13
deep brain-stimulation (12) 12
dopamine agonists (12) 12
dopamine receptors (12) 12
drug delivery systems (12) 12
infusion (12) 12
disease models, animal (11) 11
dopamine - metabolism (11) 11
dose-response relationship, drug (11) 11
drugs (11) 11
fluctuations (11) 11
follow-up (11) 11
movement disorders (11) 11
randomized controlled-trial (11) 11
term-follow-up (11) 11
therapy (11) 11
antiparkinson agents - pharmacology (10) 10
apomorphine - adverse effects (10) 10
carbidopa (10) 10
carbidopa - therapeutic use (10) 10
complications and side effects (10) 10
continuous infusion (10) 10
continuous subcutaneous infusion (10) 10
dosage and administration (10) 10
levodopa - pharmacokinetics (10) 10
parkinson disease (10) 10
severity of illness index (10) 10
apomorphine - therapeutic use (9) 9
continuous apomorphine infusion (9) 9
continuous drug delivery (9) 9
dopa-induced dyskinesia (9) 9
drug therapy, combination (9) 9
dyskinesias - drug therapy (9) 9
infusions, parenteral (9) 9
medical and health sciences (9) 9
medicin och hälsovetenskap (9) 9
medicine & public health (9) 9
parkinson disease - therapy (9) 9
quality of life (9) 9
receptor stimulation (9) 9
rotigotine (9) 9
clinical trials as topic (8) 8
complications (8) 8
delayed-action preparations (8) 8
dyskinesia, drug-induced - prevention & control (8) 8
efficacy (8) 8
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (147) 147
Spanish (6) 6
German (4) 4
French (3) 3
Polish (3) 3
Hungarian (2) 2
Czech (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, ISSN 0720-4299, 09/2017, Volume 85, Issue 9, pp. 516 - 535
Journal Article
Journal Article
REVISTA DE NEUROLOGIA, ISSN 0210-0010, 11/2012, Volume 55, pp. S25 - S29
Subcutaneous nodules and neuropsychiatric complications are the most relevant adverse effects during apomorphine infusion treatment. Subcutaneous nodules... 
Neuropsychiatric complications | STIMULATION | VISUAL HALLUCINATIONS | Continuous apomorphine infusion | FOLLOW-UP | DISORDERS | Apomorphine | CLINICAL NEUROLOGY | Nodules | Treatment | ADVANCED PARKINSONS-DISEASE | PANNICULITIS | THERAPY | Sleep Wake Disorders - chemically induced | Humans | Dopamine Agonists - therapeutic use | Drug Eruptions - therapy | Mental Disorders - prevention & control | Dopamine Agonists - adverse effects | Drug Eruptions - prevention & control | Parkinson Disease - drug therapy | Apomorphine - therapeutic use | Adrenal Cortex Hormones - therapeutic use | Apomorphine - adverse effects | Psychomotor Agitation - drug therapy | Psychoses, Substance-Induced - prevention & control | Antiparkinson Agents - therapeutic use | Psychomotor Agitation - etiology | Antipsychotic Agents - therapeutic use | Physical Therapy Modalities | Severity of Illness Index | Drug Eruptions - etiology | Hallucinations - drug therapy | Disease Susceptibility | Mental Disorders - chemically induced | Apomorphine - administration & dosage | Apomorphine - pharmacokinetics | Hallucinations - chemically induced | Dopamine Agonists - pharmacokinetics | Sleep Wake Disorders - therapy | Combined Modality Therapy | Parkinson Disease - psychology | Antiparkinson Agents - adverse effects | Hallucinations - etiology | Infusions, Subcutaneous | Antiparkinson Agents - pharmacokinetics | Dopamine Agonists - administration & dosage | Psychoses, Substance-Induced - etiology | Antiparkinson Agents - administration & dosage | Cholinesterase Inhibitors - therapeutic use
Journal Article
Journal of Neurology, ISSN 0340-5354, 11/2013, Volume 260, Issue 11, pp. 2701 - 2714
Journal Article
Archives of Gerontology and Geriatrics, ISSN 0167-4943, 2004, Volume 38, pp. 291 - 296
This study was performed to assess whether patients with Parkinson's disease (PD) develop cognitive and psychiatric impairments more frequently during therapy... 
Continuous apomorphine infusion | Neuropsychiatric impairments | Parkinson's disease | SUBCUTANEOUS APOMORPHINE | neuropsychiatric impairments | continuous apomorphine infusion | GERIATRICS & GERONTOLOGY
Journal Article
Journal Article
Journal Article
DRUGS & AGING, ISSN 1170-229X, 09/2019, Volume 36, Issue 9, pp. 807 - 821
Levodopa is the mainstay of treatment in Parkinson's disease (PD). As the disease progresses, variations in plasma levodopa levels lead to motor fluctuations.... 
MOTOR FLUCTUATIONS | LEVODOPA-INDUCED DYSKINESIA | EXTENDED-RELEASE CAPSULES | ORALLY DISINTEGRATING TABLETS | DOUBLE-BLIND | PHARMACOLOGY & PHARMACY | CONTINUOUS APOMORPHINE INFUSION | PLACEBO-CONTROLLED TRIAL | LONG-TERM TREATMENT | ROTIGOTINE TRANSDERMAL SYSTEM | CARBIDOPA INTESTINAL GEL | GERIATRICS & GERONTOLOGY
Journal Article